Colgate-Palmolive Company $CL Stock Bought by VIRGINIA RETIREMENT SYSTEMS ET Al

VIRGINIA RETIREMENT SYSTEMS ET Al increased its position in shares of Colgate-Palmolive Company (NYSE:CL) by 12.2% in the third quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 1,359,738 shares of the company’s stock after buying an additional 147,800 shares during the quarter. Colgate-Palmolive accounts for about 0.7% of VIRGINIA RETIREMENT SYSTEMS ET Al’s portfolio, making the stock its 20th biggest holding. VIRGINIA RETIREMENT SYSTEMS ET Al owned about 0.17% of Colgate-Palmolive worth $116,013,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also bought and sold shares of the company. Cooper Financial Group boosted its position in Colgate-Palmolive by 4.0% during the 2nd quarter. Cooper Financial Group now owns 2,947 shares of the company’s stock worth $270,000 after acquiring an additional 114 shares during the last quarter. Gould Capital LLC raised its holdings in shares of Colgate-Palmolive by 38.7% in the first quarter. Gould Capital LLC now owns 412 shares of the company’s stock valued at $35,000 after purchasing an additional 115 shares during the last quarter. Redhawk Wealth Advisors Inc. raised its holdings in shares of Colgate-Palmolive by 2.8% in the second quarter. Redhawk Wealth Advisors Inc. now owns 4,326 shares of the company’s stock valued at $397,000 after purchasing an additional 118 shares during the last quarter. SVB Wealth LLC lifted its position in shares of Colgate-Palmolive by 1.4% in the second quarter. SVB Wealth LLC now owns 8,767 shares of the company’s stock worth $804,000 after purchasing an additional 119 shares in the last quarter. Finally, Sowell Financial Services LLC lifted its position in shares of Colgate-Palmolive by 2.1% in the third quarter. Sowell Financial Services LLC now owns 5,737 shares of the company’s stock worth $490,000 after purchasing an additional 119 shares in the last quarter. Institutional investors and hedge funds own 80.41% of the company’s stock.

Colgate-Palmolive Price Performance

Shares of CL opened at $95.35 on Friday. The company’s 50-day moving average is $89.54 and its 200-day moving average is $89.65. The company has a debt-to-equity ratio of 13.82, a current ratio of 1.03 and a quick ratio of 0.67. The firm has a market capitalization of $76.01 billion, a PE ratio of 24.39, a PEG ratio of 4.51 and a beta of 0.33. Colgate-Palmolive Company has a fifty-two week low of $74.54 and a fifty-two week high of $99.33.

Colgate-Palmolive (NYSE:CL) last announced its earnings results on Friday, October 30th. The company reported $0.97 EPS for the quarter, topping the consensus estimate of $0.93 by $0.04. Colgate-Palmolive had a net margin of 9.68% and a return on equity of 464.63%. The business had revenue of $5.37 billion during the quarter, compared to the consensus estimate of $5.34 billion. During the same quarter in the previous year, the firm posted $0.91 EPS. Colgate-Palmolive’s revenue was up 4.6% compared to the same quarter last year. Equities analysts forecast that Colgate-Palmolive Company will post 3.87 EPS for the current year.

Colgate-Palmolive Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 13th. Shareholders of record on Tuesday, October 20th will be given a dividend of $0.53 per share. The ex-dividend date is Tuesday, October 20th. This represents a $2.12 annualized dividend and a yield of 2.2%. Colgate-Palmolive’s dividend payout ratio (DPR) is 84.13%.

Wall Street Analyst Weigh In

CL has been the subject of several recent research reports. Evercore increased their target price on shares of Colgate-Palmolive from $100.00 to $101.00 and gave the stock an “outperform” rating in a report on Thursday, October 8th. UBS Group set a $106.00 price target on shares of Colgate-Palmolive in a research note on Thursday, October 15th. Royal Bank Of Canada reiterated an “outperform” rating and issued a $104.00 price target on shares of Colgate-Palmolive in a research note on Tuesday, September 8th. Piper Sandler cut their price target on shares of Colgate-Palmolive from $98.00 to $95.00 and set an “overweight” rating on the stock in a research report on Monday, September 21st. Finally, Wells Fargo & Company reduced their price objective on shares of Colgate-Palmolive from $95.00 to $90.00 and set an “equal weight” rating for the company in a research note on Monday, October 5th. Thirteen equities research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $98.56.

More Colgate-Palmolive News

Here are the key news stories impacting Colgate-Palmolive this week:

• Positive Sentiment: Third-quarter adjusted earnings were $0.97 per share, above the roughly $0.92–$0.93 analyst consensus and up from $0.91 a year earlier. Revenue increased 4.6% year over year to $5.37 billion, also exceeding expectations. Colgate-Palmolive Surpasses Q3 Earnings and Revenue Estimates
• Positive Sentiment: Organic sales growth, pricing, higher volumes and productivity initiatives supported the quarterly beat. Management raised its 2026 base-business EPS and gross-margin outlook, signaling better profitability despite cost pressures. Colgate Q3 Earnings Beat Estimates on Organic Sales and Pricing Gains
• Positive Sentiment: The company maintained its fiscal 2026 EPS outlook while improving its base-business profitability forecast. The stronger guidance likely explains the favorable investor reaction and elevated trading activity. Colgate-Palmolive Raises FY26 Base-Business EPS View
• Neutral Sentiment: Management narrowed its full-year sales-growth outlook, suggesting that pricing and productivity—not broad-based demand—remain important drivers of performance. Colgate-Palmolive Raises Profit Outlook Despite Weak US Demand
• Negative Sentiment: Weak U.S. demand and rising input costs remain risks. The earnings beat was strong, but investors may question how sustainable margin gains will be if consumer demand softens or cost inflation accelerates. Colgate-Palmolive Q3 Analysis

Insider Transactions at Colgate-Palmolive

In other news, CEO Noel R. Wallace sold 161,021 shares of the stock in a transaction that occurred on Tuesday, August 4th. The stock was sold at an average price of $91.92, for a total transaction of $14,801,050.32. Following the transaction, the chief executive officer owned 362,231 shares in the company, valued at approximately $33,296,273.52. This trade represents a 30.77% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, COO Panagiotis Tsourapas sold 10,000 shares of the stock in a transaction that occurred on Monday, August 24th. The stock was sold at an average price of $92.05, for a total value of $920,500.00. Following the transaction, the chief operating officer owned 64,901 shares in the company, valued at approximately $5,974,137.05. This trade represents a 13.35% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 175,191 shares of company stock worth $16,110,903 over the last quarter. Company insiders own 0.43% of the company’s stock.

Colgate-Palmolive Profile

Colgate-Palmolive Company (NYSE: CL) is a global consumer products company focused on oral care, personal care, home care and pet nutrition. Its portfolio includes toothpaste, toothbrushes, mouthwash, liquid hand soap, body wash, deodorants, household cleaning products and pet food and treats.

The company markets well-known brands such as Colgate, Palmolive, elmex, meridol, Softsoap, Irish Spring, Ajax, Protex and Hill’s Science Diet. Colgate-Palmolive also provides veterinary and nutritional products through Hill’s Pet Nutrition, which serves pet owners and animal health professionals.

Founded in 1806 by William Colgate, the company developed from a soap and candle business into a diversified consumer goods manufacturer.